Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of SOM0226 in Familial Amyloid Polyneuropathy (FAP) Patients and Asymptomatic Carriers to Evaluate Protein Stabilization Activity

NCT02191826 is registered in ClinicalTrials.gov with SOM Innovation Biotech SA as lead sponsor.

NCT NCT02191826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02191826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of SOM0226 in Familial Amyloid Polyneuropathy (FAP) Patients and Asymptomatic Carriers to Evaluate Protein Stabilization Activity
Lead sponsor
SOM Innovation Biotech SA
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2014
Completion date
November 30, 2015
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

familial amyloid polyneuropathy (fap)